BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 12029139)

  • 1. Induction of cachexia in mice by systemically administered myostatin.
    Zimmers TA; Davies MV; Koniaris LG; Haynes P; Esquela AF; Tomkinson KN; McPherron AC; Wolfman NM; Lee SJ
    Science; 2002 May; 296(5572):1486-8. PubMed ID: 12029139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible role of myostatin in skeletal muscle atrophy and cachexia.
    Jespersen J; Kjaer M; Schjerling P
    Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis.
    Nakatani M; Kokubo M; Ohsawa Y; Sunada Y; Tsuchida K
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E543-53. PubMed ID: 21205933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice.
    Tang L; Yan Z; Wan Y; Han W; Zhang Y
    Muscle Nerve; 2007 Sep; 36(3):342-8. PubMed ID: 17587222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal expression of myostatin propeptide cDNA maintained high muscle growth and normal adipose tissue mass in transgenic mice fed a high-fat diet.
    Yang J; Zhao B
    Mol Reprod Dev; 2006 Apr; 73(4):462-9. PubMed ID: 16437538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin: more than just a regulator of muscle mass.
    Argilés JM; Orpí M; Busquets S; López-Soriano FJ
    Drug Discov Today; 2012 Jul; 17(13-14):702-9. PubMed ID: 22342983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance.
    Zhao B; Wall RJ; Yang J
    Biochem Biophys Res Commun; 2005 Nov; 337(1):248-55. PubMed ID: 16182246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling.
    Chandraskeharan K; Martin PT
    Muscle Nerve; 2009 Jan; 39(1):25-41. PubMed ID: 19086062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of muscle mass by myostatin.
    Lee SJ
    Annu Rev Cell Dev Biol; 2004; 20():61-86. PubMed ID: 15473835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral content and density in the humerus of adult myostatin-deficient mice.
    Hamrick MW; McPherron AC; Lovejoy CO
    Calcif Tissue Int; 2002 Jul; 71(1):63-8. PubMed ID: 12060865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle.
    Nishi M; Yasue A; Nishimatu S; Nohno T; Yamaoka T; Itakura M; Moriyama K; Ohuchi H; Noji S
    Biochem Biophys Res Commun; 2002 Apr; 293(1):247-51. PubMed ID: 12054591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice.
    Liu CM; Yang Z; Liu CW; Wang R; Tien P; Dale R; Sun LQ
    Gene Ther; 2008 Feb; 15(3):155-60. PubMed ID: 18033313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting myostatin for therapies against muscle-wasting disorders.
    Tsuchida K
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
    Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
    Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and neural control of follistatin versus myostatin genes during regeneration of mouse soleus.
    Armand AS; Della Gaspera B; Launay T; Charbonnier F; Gallien CL; Chanoine C
    Dev Dyn; 2003 Jun; 227(2):256-65. PubMed ID: 12761853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual dimorphism is associated with decreased expression of processed myostatin in males.
    McMahon CD; Popovic L; Jeanplong F; Oldham JM; Kirk SP; Osepchook CC; Wong KW; Sharma M; Kambadur R; Bass JJ
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E377-81. PubMed ID: 12388123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.